Wegovy 1 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FD9GY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $52,031
Award facts
- Contract value 100% obligated
- $52,031.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $52,031.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Wegovy 1 mg/0.5 ml pen injections (0.5 ml). The contract, which was competitively awarded without set-aside designation, is scheduled for completion by September 5, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026, which serves as a comprehensive pharmaceutical supply vehicle supporting military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies an extensive portfolio of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The Wegovy delivery order represents one of numerous pharmaceutical procurements through the SPE2DX vehicle, reflecting the company's established capability to fulfill federal medical supply requirements for military and veteran healthcare operations. The DLA Troop Support is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen as a key supplier within the evolving federal pharmaceutical procurement landscape.
Quick answers
Who was awarded contract SPE2DB25FD9GY?
SPE2DB25FD9GY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 4, 2025.
How much is contract SPE2DB25FD9GY worth?
The government has obligated $52,031 on SPE2DB25FD9GY.
Is contract SPE2DB25FD9GY an order under another contract?
Yes. SPE2DB25FD9GY is a delivery order under SPE2DB20D1051, an indefinite delivery contract.
Was contract SPE2DB25FD9GY competed?
The extent of competition for SPE2DB25FD9GY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award